Prof. Dr. Mathias Devreese graduated as a veterinarian in 2010 with great honors (Ghent University, Belgium). After graduation, he immediately started his Ph.D. research at the Laboratory of Pharmacology and Toxicology regarding the efficacy of mycotoxin detoxifiers and their interaction with oral absorption of veterinary drugs. During his Ph.D. research, he undertook a research stay of several months at the Department of Animal Biosciences at the University of Guelph (ON, Canada). After gaining his Ph.D. in 2013, he obtained a post-doctoral research grant from the Research Foundation Flanders (FWO) to establish a juvenile piglet model for preclinical pediatric pharmacokinetic/pharmacodynamic research. He took a research sabbatical in 2016 to gain more in-depth knowledge regarding compartmental and population pharmacokinetic modeling at the Institute of Computational Comparative Medicine (ICCM) at Kansas State University (KS, USA). Since 2017, he has been an EBVS™ European Specialist in Veterinary Pharmacology and Toxicology (ECVPT Diplomat). He is currently an Associate Professor of Veterinary Pharmacology and Therapeutics at Ghent University.
Prof. Dr. Mathias Devreese graduated as a veterinarian in 2010 with great honors (Ghent University, Belgium). After graduation, he immediately started his Ph.D. research at the Laboratory of Pharmacology and Toxicology regarding the efficacy of mycotoxin detoxifiers and their interaction with oral absorption of veterinary drugs. During his Ph.D. research, he undertook a research stay of several months at the Department of Animal Biosciences at the University of Guelph (ON, Canada). After gaining his Ph.D. in 2013, he obtained a post-doctoral research grant from the Research Foundation Flanders (FWO) to establish a juvenile piglet model for preclinical pediatric pharmacokinetic/pharmacodynamic research. He took a research sabbatical in 2016 to gain more in-depth knowledge regarding compartmental and population pharmacokinetic modeling at the Institute of Computational Comparative Medicine (ICCM) at Kansas State University (KS, USA). Since 2017, he has been an EBVS™ European Specialist in Veterinary Pharmacology and Toxicology (ECVPT Diplomat). He is currently an Associate Professor of Veterinary Pharmacology and Therapeutics at Ghent University.